Skip to main navigation Skip to search Skip to main content

Immunogenic cell death in cancer: concept and therapeutic implications

  • Cornell University
  • Université Paris-Sud
  • Sonata Therapeutics
  • Centre de Recherche des Cordeliers
  • Assistance publique – Hôpitaux de Paris
  • Kite Pharma Inc.

Research output: Contribution to journalReview articlepeer-review

158 Scopus citations

Abstract

Mammalian cells responding to specific perturbations of homeostasis can undergo a regulated variant of cell death that elicits adaptive immune responses. As immunogenic cell death (ICD) can only occur in a precise cellular and organismal context, it should be conceptually differentiated from instances of immunostimulation or inflammatory responses that do not mechanistically depend on cellular demise. Here, we critically discuss key conceptual and mechanistic aspects of ICD and its implications for cancer (immuno)therapy.

Original languageEnglish
Article number162
Pages (from-to)162
JournalJournal of Translational Medicine
Volume21
Issue number1
DOIs
StatePublished - Feb 2 2023
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Animals
  • Cell Death
  • Cell Differentiation
  • Homeostasis
  • Immunogenic Cell Death
  • Mammals
  • Neoplasms/therapy

Fingerprint

Dive into the research topics of 'Immunogenic cell death in cancer: concept and therapeutic implications'. Together they form a unique fingerprint.

Cite this